{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:01:30Z","timestamp":1758758490629,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,23]]},"DOI":"10.7759\/cureus.93054","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:18:56Z","timestamp":1758669536000},"source":"Crossref","is-referenced-by-count":0,"title":["Oral Corticosteroid Use and Its Associated Complications in Patients With Sarcoidosis: A Nationwide Claims Study From Japan"],"prefix":"10.7759","author":[{"given":"Koichi","family":"Miyashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre D","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet. 2014, 383:1155-67. 10.1016\/S0140-6736(13)60680-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve P","year":"2021","unstructured":"S\u00e8ve P, Pacheco Y, Durupt F, et al.. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021, 10:766. 10.3390\/cells10040766","journal-title":"Cells"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman RP","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, et al.. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021, 58:2004079. 10.1183\/13993003.04079-2020","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.22.7.833","article-title":"Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma","volume":"22","author":"Dalal AA","year":"2016","unstructured":"Dalal AA, Duh MS, Gozalo L, et al.. Dose-response relationship between long-term systemic corticosteroid use and related complications in patients with severe asthma. J Manag Care Spec Pharm. 2016, 22:833-47. 10.18553\/jmcp.2016.22.7.833","journal-title":"J Manag Care Spec Pharm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001220","article-title":"Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis","volume":"8","author":"Wu J","year":"2020","unstructured":"Wu J, Mackie SL, Pujades-Rodriguez M. Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Res Care. 2020, 8:e001220. 10.1136\/bmjdrc-2020-001220","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07023-6","article-title":"Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90\u00a0days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan","volume":"35","author":"Iki M","year":"2024","unstructured":"Iki M, Fujimori K, Nakatoh S, et al.. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90\u00a0days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan. Osteoporos Int. 2024, 35:805-18. 10.1007\/s00198-024-07023-6","journal-title":"Osteoporos Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1767-1","article-title":"Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort","volume":"21","author":"Chaudhary NS","year":"2017","unstructured":"Chaudhary NS, Donnelly JP, Moore JX, Baddley JW, Safford MM, Wang HE. Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort. Crit Care. 2017, 21:185. 10.1186\/s13054-017-1767-1","journal-title":"Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa TP","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000, 15:993-1000. 10.1359\/jbmr.2000.15.6.993","journal-title":"J Bone Miner Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions","volume":"33","author":"Balasubramanian A","year":"2018","unstructured":"Balasubramanian A, Wade SW, Adler RA, Saag K, Pannacciulli N, Curtis JR. Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J Bone Miner Res. 2018, 33:1881-8. 10.1002\/jbmr.3523","journal-title":"J Bone Miner Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00767-2020","article-title":"Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study","volume":"56","author":"Rossides M","year":"2020","unstructured":"Rossides M, Kullberg S, Eklund A, Di Giuseppe D, Grunewald J, Askling J, Arkema EV. Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study. Eur Respir J. 2020, 56:2000767. 10.1183\/13993003.00767-2020","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106622","article-title":"Patterns of medication use and imaging following initial diagnosis of sarcoidosis","volume":"189","author":"Simmering J","year":"2021","unstructured":"Simmering J, Stapleton EM, Polgreen PM, Kuntz J, Gerke AK. Patterns of medication use and imaging following initial diagnosis of sarcoidosis. Respir Med. 2021, 189:106622. 10.1016\/j.rmed.2021.106622","journal-title":"Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0871-3","article-title":"Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study","volume":"19","author":"Yoon HY","year":"2018","unstructured":"Yoon HY, Kim HM, Kim YJ, Song JW. Prevalence and incidence of sarcoidosis in Korea: a nationwide population-based study. Respir Res. 2018, 19:158. 10.1186\/s12931-018-0871-3","journal-title":"Respir Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan H","year":"2011","unstructured":"Quan H, Li B, Couris CM, et al.. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011, 173:676-82. 10.1093\/aje\/kwq433","journal-title":"Am J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.05.009","article-title":"Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis","volume":"46","author":"Broder MS","year":"2016","unstructured":"Broder MS, Sarsour K, Chang E, Collinson N, Tuckwell K, Napalkov P, Klearman M. Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis. Semin Arthritis Rheum. 2016, 46:246-52. 10.1016\/j.semarthrit.2016.05.009","journal-title":"Semin Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan PW","year":"2018","unstructured":"Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018, 141:110-16.e7. 10.1016\/j.jaci.2017.04.009","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.83328","article-title":"Current epidemiological and clinical features of sarcoidosis in Japan: a nationwide claims data study","volume":"17","author":"Miyashita K","year":"2025","unstructured":"Miyashita K, Hashimoto K, Maeda S, Suda T. Current epidemiological and clinical features of sarcoidosis in Japan: a nationwide claims data study. Cureus. 2025, 17:e83328. 10.7759\/cureus.83328","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/209832","article-title":"Clinically diagnosed insomnia and risk of all-cause and diagnosis-specific disability pension: a nationwide cohort study","volume":"2013","author":"Jansson C","year":"2013","unstructured":"Jansson C, Alexanderson K, Kecklund G, Akerstedt T. Clinically diagnosed insomnia and risk of all-cause and diagnosis-specific disability pension: a nationwide cohort study. Sleep Disord. 2013, 2013:209832. 10.1155\/2013\/209832","journal-title":"Sleep Disord"},{"key":"ref18","unstructured":"The R Project for statistical computing. (2024). Accessed. June 17, 2025: https:\/\/www.R-project.org\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol EI","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al.. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015, 12:e1001885. 10.1371\/journal.pmed.1001885","journal-title":"PLoS Med"},{"key":"ref20","unstructured":"Ethical guidelines for medical and health research involving human subjects. (2015). Accessed. July 31, 2025: https:\/\/warp.da.ndl.go.jp\/info:ndljp\/pid\/11656272\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10600000-Daijinkanboukouseikag...."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18916\/9784771905832","article-title":"Sarcoidosis Treatment Guide 2023 [Book in Japanese]","author":"Japanese Society of Sarcoidosis\/Granulomatous Disease","year":"2023","unstructured":"Japanese Society of Sarcoidosis\/Granulomatous Disease. Sarcoidosis Treatment Guide 2023 [Book in Japanese]. Katsuseido Publishing, Tokyo; 2023. 10.18916\/9784771905832"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201610-750OC","article-title":"Sarcoidosis increases risk of hospitalized infection. A population-based study, 1976-2013","volume":"14","author":"Ungprasert P","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Sarcoidosis increases risk of hospitalized infection. A population-based study, 1976-2013. Ann Am Thorac Soc. 2017, 14:676-81. 10.1513\/AnnalsATS.201610-750OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis JR","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison J, et al.. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006, 55:420-6. 10.1002\/art.21984","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402103-oral-corticosteroid-use-and-its-associated-complications-in-patients-with-sarcoidosis-a-nationwide-claims-study-from-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:18:58Z","timestamp":1758669538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402103-oral-corticosteroid-use-and-its-associated-complications-in-patients-with-sarcoidosis-a-nationwide-claims-study-from-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.93054","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}